Biosergen AS (BIOSGN) — Financial Flexibility Index
Biosergen AS (BIOSGN) has a Financial Flexibility Index of -0.59x as of December 2025. Free cash flow of Skr-7.75 Million (operating CF Skr-7.75 Million minus capex Skr0.00) represents -1% of total liabilities (Skr13.04 Million). Check Biosergen AS investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biosergen AS Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Biosergen AS across 7 annual periods. For the full cash flow conversion analysis, see BIOSGN operating cash flow.
Annual Financial Flexibility Index for Biosergen AS (2019–2025)
Year-by-year free cash flow to debt coverage for Biosergen AS. Explore BIOSGN operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.73x | Skr-35.53 Million | Skr-35.53 Million | Skr13.04 Million | ▲ +39.2% |
| 2024 | -4.48x | Skr-16.63 Million | Skr-16.63 Million | Skr3.71 Million | ▲ +30.1% |
| 2023 | -6.41x | Skr-32.60 Million | Skr-32.60 Million | Skr5.08 Million | ▼ -139.5% |
| 2022 | -2.68x | Skr-29.44 Million | Skr-29.44 Million | Skr11.00 Million | ▲ +34.4% |
| 2021 | -4.08x | Skr-37.75 Million | Skr-37.75 Million | Skr9.25 Million | ▼ -1299.1% |
| 2020 | -0.29x | Skr-4.58 Million | Skr-4.58 Million | Skr15.72 Million | ▼ -43.2% |
| 2019 | -0.20x | Skr-2.31 Million | Skr-2.31 Million | Skr11.37 Million | — |